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Application of arachidonic acid (AA) (0.1-4 mg) to the 
ears of mice produces immediate vasodilatation and er-
ythema (5 min) followed by the abrupt development of 
edema which is maximal at 40-60 min. The onset of 
edema coincides with extravasation of protein and leu-
kocytes. After 1 h, the edema begins to wane rapidly 
and the inflammatory cells leave the tissue so that by 6 
h the ears have returned to near normal except for 
residual erythema. During the period 6-48 h , AA-
treated ears show a greatly diminished response with 
respect to edema and cell infiltrate when AA is applied 
a second time. Inhibitor studies show that the inflam-
matory response is due to formation of AA metabolites 
via both the cyclooxygenase and lipoxygenase path-
w-ays. Under appropriate conditions, AA-induced ear 
edema can be used as a model to screen for compounds 
showing in vivo lipoxygenase inhibitory activity. Al-
though relatively large doses of AA were applied topi-
cally, there was only a modest stimulation of epidermal 
DNA synthesis and mitotic index with no consequent 
hyperplasia. Although arachidonic acid is capable of 
eliciting most aspects of an inflammatory response, the 
reaction is abrupt in onset and of short duration. Addi-
tional factors appear to be required to produce a pro-
longed inflammatory response with associated tissue de-
struction, or inflammatory cell activation and immobi-
lization in situ. 
As a result of the therapeutic success of nonsteroidal agents 
t hat act by inhibit ion of cyclooxygenase, there is considerable 
t heoretical and practical interest in developing and determining 
t he propert ies of agents t hat act selectively against the lipoxy-
genase pathway of arachidonic acid (AA) metabolism. In a 
previous paper [l ] we briefly described the inflammatory re-
sponse of mouse ears to the topical application of AA, and 
s howed that it was of very short duration. Whereas the response 
to 12-0-tetradecanoylphorbol acetate (TPA) could be inhibited 
or delayed by nonsteroidal agents that act preferentially against 
t h e cyclooxygenase pathway of AA metabolism, inhibition of 
AA-induced edema appeared to be restricted to agents that had 
t he additional property of inhibiting the lipoxygenase pathway 
of AA metabolism. Since compounds t hat are predominantly, 
if not exclusively, lipoxygenase inhibitors were found to be very 
effective at inhibiting AA-induced ear edema, it appeared that 
t his might represent a useful model for the rapid in vivo 
screening of agents showing se lect ive activity against AA lipox-
ygenase enzymes. With t his potential in mind, we have more 
fully characterized t he mouse ear inflammatory response to 
topical AA, wi t h respect to specificity, time course, vascular 
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leakage a nd cell infilt rate, and t he role of mediators other t han 
those derived from AA. 
MATERIALS AND METHODS 
Female mice (Sim: (SW)fBR, Simonsen Labs, Gi lroy, California) 6-
10 weeks old were caged together in t reatment groups of 8 unless 
otherwise stated. Animals were acclimated for 1 week before use. All 
experimental procedures were performed without. anesthesia , and ani -
mals were killed by cervical dislocation. 
Arachidonic ac id (Sigma Chemical Co. , St. Louis, Missouri; Grade 
1, approx. 99 %) was dissolved in reagent-grade acetone at 200 mg/ ml 
a nd stored at -20"C for no longer t han 1 week. Othe r unsaturated 
ac ids (Sigma Chemica l Co.) were greater t ha n 95 % pure. [methyl -"HJ 
Thymidine, 6.7 1-'Ci/ mmol in steril e wa te r (New E ngland Nuclear, 
Boston, Massachusetts) was diluted in sterile saline to 100 1-'Ci/ ml. 
Evans Blue (M CB, Norwood, Ohio) was prepared as a 1% solu tion in 
phosphate-buffered saline , fi ltered, and stored in a sterile bott le at 
room temperature. Tissues were digested fo r scin tillation counting in 
NCS Tissue Solubilize r (Amersham Corp. , Arlington Heights, Illinois). 
Edema Induction and 111easurement 
Arachidonic ac id in acetone was applied in volumes of 0.01 ml to 
eac h of t he inner and outer surfaces of t he right ear by means of an 
automatic microli te r pipet. This vo lume was found to spread evenly 
ove r the whole surface of t he ear with minimal dra inage to the base 
and s kull. Potentia l inhibitors were simila rly app lied as solutions in 
acetone, ethanol, or aqueous ethanol as appropriate, usually 30 min 
prior to AA application. App ropriate solvent cont rols were run in each 
experiment:. 
For ear thickness determinat ions, an Odi test dia l gauge caliper (0-
0.8 inches with graduations of 0.001 inches) was modified t.o increase 
t he contact a rea and reduce the tension. The calipers were app lied near 
t he tip of t he ear just distal to t he cartil aginous ridges and t hickness 
was recorded in uni ts of 0.001 inches. In some experiments, a Peacock 
dial thickness gauge, calibrated in metric units, was used. To minimize 
va riation due to techn ique, measurements throughou t any one expe ri -
ment were performed by a si ngle investigator . T his method a llowed 
edema development in s ingle animals or groups of animals to be 
fo llowed through time. Edema was a lso determined on t he basis of ear 
plug weight in certai n experiments in which a nimals were killed a nd 
the ears were quick ly removed at t he base. P lugs were then obtained 
from the tip of each ea r wit.h a biopsy punch and these were weighed 
to t he nea rest 0.1 mg as soon as possible. 
Evans Blue and {'H) Thymidine ({'H}Thd) Accumulation 
Mice in groups of 8 were injected via t he latera l ta il vein with 0.25 
ml of 1% Evans Blue in phosphate-buffered sa line. Afw r 20 o r 30 min 
(see Results), t he animals were kil led and both ears were removed; 8-
mm plugs obtained from each ear were weighed and t hen transferred 
to 16 X 100 mm tubes togethe r with 0.5 ml NCS Tissue Solubilize r. 
The tubes were incubated in a wate r bath at 37"C overnight and for an 
addi t iona l hour at 55"C t.o ensure that t he t issues were completely 
digested. After cooling, .1.0 ml ethyl acetate and 1.0 ml of 1.0 N 
hydrochloric acid were added with vortex mixing after each addition. 
The t.ubes were cent rifuged at 500 g for 15 min to separa te the phases, 
and t he Evans Blue dye concent rat ion was determined spectrophoto-
metrically at 620 nm. Under these conditions t he Evans Blue dye is 
co mpletely released from t he dissolved t issues and qua nt itative ly ex-
tracted in to t he ethyl acetate layer. The t ube and volumes were chosen 
so that optical dens ity (00) determinations could be performed in a 
Bausch a nd Lomb Spectronic 20 without t he need to t ra nsfer t he ethyl 
acetate laye r to another tube or cuvette. This is a modjfication of the 
method of Beach and Steinetz [2] in which tissues were digested in 
ac id and the released Evans Blue was ext racted into a n organic phase 
wi t h t he a id of benzalkonium chloride. The left un treated ear of each 
368 YOUNG ET AL 
animal served as the control and the 00 for the left ear was subtracted 
from the 00 from the right ear. 
For the [3H)Thd accumulation studies, animals were injected i.p. 
with 1 pCi/g body weight 24 h prior to induction of the inflammation. 
At appropriate times after AA or TPA application, groups of animals 
were killed and both ears were removed. Eight-millimeter plugs from 
both ears, treated and control, were weighed and digested in NCS 
Tissue Solubilizer as described above. The digests were diluted with 
scintillation fluid, counted, and the appropriate quench corrections 
applied. The ratio of radioactivity in the treated ear relative to the 
control ear was ca lculated for each a nimal and taken as a measure of 
influx of labeled inflammatory cells [3). In cases where it was desirable 
to measure Evans Blue leakage and [3H]Thd accumulation in the same 
a nimals, the tissues were prepared as described for the Evans Blue 
determinations a nd then aliquots of the lower aqueous phase were 
removed for liquid scin t illation counting. 
Histologic Procedure:; 
Animals were killed by cervica l dislocation, the infla med ears were 
removed and fixed in neutral buffered formalin. Tissues were dehy-
drated, paraffin embedded, and sectioned at 7 pm. Slides were stained 
with hematoxylin-eosin or with Giemsa. Epidermal mitotic counts for 
eac h animal were obta ined by examining at least 5 em of in terfollicula r 
epiderm is in independen t sections. 
/£pidermal DNA Synthesis 
Animals were treated with AA or acetone on both ears, and at 
appropriate t imes groups of mice were injected i.p. with ["H]Thd (1 
11Ci / g body weight) and killed 30 min later. Ears were removed, placed 
in a beaker of water, subjected to microwave irradiation, a nd the 
epidermis was harvested for DNA determination and liquid scintillation 
counting as previously described [4) . 
RESULTS 
Time Course, Dose Response, and Specificity 
Application of 4 mg AA in acetone produced vasodilatation 
and hyperemia within 5 min. Edema (Fig 1A) became detecta-
ble by 15 min and was maximal at 40-60 min. Thereafter, the 
edema decreased rapidly, with ear thickness returning to near 
control levels b~· 6 h, although the erythema remained. Ery-
thema was barely detectable after 24 h. Previously we had 
shown that doses as low as 0.4 mg produced some edema 
whereas 0.04 mg produced only erythema and vasodilatation 
[1] . From the dose- response curve (Fig 1B), the threshold dose 
for edema is approximately 0.1 mg and the EDoo is 0.4 mg with 
a maximal response occurring at or above 3 mg. Since these 
doses appeared high, the specificity of the response was exam-
ined. Eicosa-8,11,14-trienoic acid at 4 mg/ear produced only a 
modest response as shown in Fig 1A. 11 ,14,17-Eicosatrienoic 
acid, 6,9,12-octadecatrienoic acid, 9,12,15-octadecatrienoic 
acid, 9,12-octadecadienoic acid (all at 4 mg/ear) and 9-octadec-
enoic acid at 20 mg/ear did not produce edema alone nor in 
ears made erythematous with 40 J.Lg of prostaglandin E" (PGEJ. 
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Vol. 82, No.4 
Vascular Leakage and Inflammatory Cell Accumulation 
Histologic examination of AA-treated ears had previously 
shown [1] that at 1 h, large numbers of both polymorphonuclear 
leukocytes (PMNLs) and monocytes were present in the dermis 
and that some of the larger vessels were partially occluded with 
white thrombi. At 3 h, the number of extravascular leukocytes 
appeared decreased, although cell counting was not attempted 
because of the large variation in residual edema between sam-
ples. However, by 6 h very few inf1ammatory cells could be 
detected at a ll. 
Since the histology had clearly shown large numbers of 
extravascular leukocytes at 1 h, and their subsequent disap-
pearance by 6 h, an attempt was made to quantitate this 
phenomenon using the technique ofprelabeling leukocytes with 
["H]Thd [3,5]. Mice were injected with ["H]Thd and 24 h later 
t reated with AA as shown in Table I. Data for TPA-treated 
mice are included for comparison. Since ["H]Thd is rapidly 
incorporated into DNA at the time of inject ion [6], any increase 
in radioactivity of the inf1amed ear over the control ear 24 h 
later should be due to the influx of circulating leukocytes 
carrying the label [3,5,6]. This radio labeling technique confirms 
the histologic observations to the extent that there is a large 
increase in radioactivity 1 h after AA application; radioactivity 
is reduced at 3 h; and by 6 and 24 h the majority of radio labeled 
cells have left the ear. In contrast, cell accumulation in TPA-
treated ea rs occurs more slowly and cells persist in the tissue 
in substantial, and histologically obvious, numbers for at least 
48 h [1) . 
Since AA-induced ear edema reached a maximum at 40-60 
min and decreased rapidly thereafter, it was of interest to assess 
vascular permeability in relation to tissue edema. As shown in 
Fig 2, animals were injected with Evans Blue at intervals and 
the relative tissue accumulation of dye was determined 30 min 
later. There is a high degree of permeability over the first 30 
min but this decreases rapidly so that there is very little dye 
leakage after 60 min in spite of continued tissue edema. 
Investigation of Evans Blue leakage (Fig 2) and cellular 
infiltration (data not shown) in AA-treated ears at 20-min 
intervals during the first hour showed that dye and cell accu-
mulation coincide with the onset of edema or fluid leakage, 
being half max imal at 20 min and nearly complete by 40 min. 
Diminished Response to Second AA Application 
Since AA-induced int1ammation waned so rapidly, attempts 
were made to boost the response with a second application of 
AA. As we had shown previously for TPA-induced ear edema 
[1], there appeared to be a period of specific unresponsiveness 
following the initial application. The tachyphylaxis to AA was 
most dramatic at 5-6 has shown in Fig 3, but was still apparent 
at 24 h. Beyond 24 h the effect was much reduced but still 
significant at 96 h. Cell accumulation using ["H]Thd (see above) 
in response to a second application of AA at 24 h was found to 
correlate directly with edema, showing a correspondingly di-
minished response (data not shown). In other experiments, 
animals showed little or no response when AA was applied to 
an ear inflamed 6 h previously, but a maximal response was 
obtained if the second dose of AA was applied to the contralat-
eral noninflamed ear. 
Epidermal Response to AA 
Previously we had observed an increased number of epider-
mal mitoses, but no hyperplasia, 24 and 48 h after a single 
application of 4 mg AA [1], but we did not obtain quantitative 
data. A detailed examination including mitotic counts of t he 
epidermal response to graded doses of AA is shown in Table II. 
AA produced a dose-related edema at 1 h and a corresponding 
increase in mitotic counts at both 24 and 48 h. 
In order to assess the effect of AA on DNA synthesis, 
epidermal DNA was isolated from groups of animals at appro-
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TABLE I. Comparative time course of edema and migration of (JH}Thd labeled inflammatory cells in the mouse ear after AA or TPA 
Hours post 
AA 
Ear plug (6 mm) Weight, Mg ± SO I"HJ -Thd in ear plugs N 
Control Inflamed Ratio Ratio inflamed/control 
0 
1 
3 
6 
8 5.6 ± 0.2 5.5 ± 0.1 1.00 ± .04 0.98 ± 0.07 
8 5.9 ± 0.3 16.7 ± 1.3 2.84 ± .32 2.78 ± 0.40" 
8 5.5 ± 0.4 13.3 ± 1.7 2.41 ± .40 2.41 ± 0.65" 
8 5.6 ± 0.3 8.7 ± 1.7 1.57 ± .26 1.50 ± 0.32" 
24 5 6.3 ± 0.2 8.0 ± 0.5 1.27 + .06 1.28 + 0.24 
Hours post 
TPA 
Ear plug (8 mm) weight, Mg ± SO ['Hj -Thd in ear plugs N 
Control Inflamed Ratio Ratio inflamed/control 
1.5 
3.0 
4.5 
6.0 
4 14.2 ± 0.9 14.3 ± 1.3 0.99 ± .02 0.97 ± 0.09 
4 14.8 ± 1.3 28.8 ± 4.9 1.94 ± .23 1.92 ± 0.07" 
4 13.1 ± 0.8 35.8 ± 1.4 2.73 ± .08 3.02 ± 0.16" 
4 13.0 ± 1.4 36.5 ± 2.5 2.82 ± .34 3.26 ± 0.35" 
24 
48 
4 13.9 ± 1.2 19.7 ± 4.8 1.40 ± .25 2.04 ± 0.67" 
4 14.9 ± 0.4 18.2 ± 1.0 1.22 ± .05 2.18 ± 0.47" 
• Significantly different from 1.0 at p < 0.05. 
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FIG 2. Ear plug weight and Evans Blue dye accumulation after 4 
mg AA. Ear plugs (8 mm) were taken at the times shown after AA 
application and weighed (e) . For determination of vascular leakage, 
animals were injected with Evans Blue dye 30 min (0) or 20 min (L'l) 
prior to sac rifice, and ear plugs fro m control and AA-treated ears were 
digested for dye determination as described in MateriaL~ and Methods. 
Each point represents the mean± SD of the ear thickness of 8 animals 
in units of 0.001 inches. 
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F IG 3. Diminished edema response to reapplication of 4 mg AA. 
Mice were t reated with AA at 0 h (e) and ear th ick ness was determined 
with calipers. At 5 h, 24 h, or 48 h groups of mice received AA again 
(~); for each time point, animals which had received acetone at 0 h 
were similarly t reated with 4 mg AA (0). Each point represents the 
mean ± SD of t he ear t hckness of 8 an imals in units of 0.001 inches. 
TABLE II. Effect of topical AA on epidermal mitotic counts 
AA dose Ear th ickness units Mitoses per em epidermis• 
mg/ear (0.00 1 ") at I h" 24 h 48 h 
3 14.7 ± 2.5' 22.0 ± 7.9' 6.8 ± 2.8' 
1 14.0 ± 2.2' 7.5 ± 2.8d 5.5 ± 1.7' 
0.3 11.4 ± 2.0' 5.5 ± 1.9'" 3.7 ± 2.0 
0.1 9.3 ± 0.8' 2.7 ± 2.3 3.6 ± 2.3 
Acetone 8.2 ± 0.4 2.6 ± 1.4 2.7 ± 1.3 
" Mean ± SD, n = 15. 
• Mean± SD, minimum of 5 em examined from each of 5 an imals. 
' p < 0.001 vs acetone control. 
d p < 0.01 vs acetone control. 
' p < 0.05 vs acetone control. 
TABLE III . Effect of topical AA on mouse ear epidermal DNA 
synthesi:;" 
Hours post DNA recovered, pg ± SO DNA sp act, dpm/pg ±SO 
AA Acetone AA Acetone AA 
1 42.6 ± 9.2 38.6 ± 5.9 7.9 ± 2.5 12.5 ± 3.8 
5 20.5 ± 3.2 48.4 ± 5.8• 8.1 ± 1.4 10.5 ± 3.9 
10 30.9 ± 11.6 48.9 ± 8.2 14.8 ± 3.1 14.4 ± 3.1 
24 35.6 ± 2. 1 53.3 ± 9.3' 10.4 ± 2.0 44.3 ± 2.7d 
48 31.9 ± 7.7 62.5 ± 20.4 12.6 ± 1.0 20.4 ± 5.3 
"Each value obtained from t he epidermis of 9 mice pooled in groups 
of 3. 
1
' p < 0.01. 
' p < 0.05. 
d p < 0.001. 
priate intervals 1/2 h after an injection of ["H]Thd and t he 
specific activity was determined. As shown in Table III , AA 
produced an increase in recoverable DNA but no increase in 
specific activity at 5 h, which may reflect the presence of some 
in flammatory cells in the epidermis. At 24 h, there was an 
increase in both recoverable DNA and specific activity which 
corresponds to the increase in mitotic counts observed in h is-
tologic sections. 
Jn/u:bition of AA-Induced Ear Edema 
In order to assess indirectly t h e relative importance of prod-
ucts from the various pathways of AA metabolism, the effects 
of various cyclooxygenase and/or lipoxygenase inhibitors [7,8] 
were examined for their ability to modify AA-induced edema. 
The rapidity of t h e reaction required that the test compounds 
be applied prior to AA, and, therefore, interference with pene-
tration of the latter could not be entirely excluded. For this 
reason, the assays shown in Table IV were carried out using a 
challen ge dose of 4 mg AA per ear, in order to ensure a maximal 
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TABLE IV. Effect of topically applied compounds on AA ear edema" 
Co mpound Dose, 
rng/ear 
% 
Inhib ition 
Cyclooxygenase Inhibi tors 
Naproxen 2 0 
Indomethac in 3 21" 
Phenylbutazone 5 0 
Lipoxygenase/cyclooxyge nase inhibitors 
Nordihydrogua ia retic acid 2 43 
Phenidone 2 67 
Lipoxygenase inhibitors 
Diphenyldisulfide 2 43 
Hydroquinone 2 50 
" Effect of each dose of compound was dete rmined in 8 animals 
compa red wi t h appropriate posi t ive a nd negative cont rol groups. 
" This was t he greatest inhibi t ion observed in 3 experiments bu t was 
still not s ignificantly (p < 0.05) different from controls . 
response (cf. Fig 1B) and minimize interference with penetra-
tion . 
Under these conditions, compounds that are predominantly 
cyclooxygenase inhibitors [7] showed little or no inhibitory 
activity, although it was observed that naproxen suppressed 
t he erythema (see below). Phenidone and nordihydroguaiaretic 
acid are strong lipoxygenase inhibitors but also show some 
activity against cyclooxygenase [7], whereas diphenyldisulfide 
[8] and hydroquinone [7] are relatively specific lipoxygenase 
inhibitors. Both groups of compounds were good inhibitors. 
Naproxen Modification of AA-Induced Ear Edema 
Since naproxen showed no significant effect against 4 mg AA 
when tested on a number of occasions, it was tested against 
lower doses of AA as shown in Fig 4. Naproxen at 2 mg 
signilicantly enhanced the edema resulting from application of 
2 mg AA at all t ime points examined. Against 0.5 mg AA, 
naproxen was strongly inhibitory. These results were confirmed 
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in a second experiment (not shown) using 1.5 mg AA as the 
intermediate and 0.5 mg AA as the low dose. In all cases, 
naproxen consistently reduced ear redness regardless of the 
effect on edema. 
DISCUSSION 
In a long list of mediators, including histamine, serotonin, 
the kinins, complement, etc. , the metabolites of AA have be-
come the recent focus of attention. Alone or in appropriate 
combination, AA products of the cyclooxygenase and lipoxy-
genase pathways are capable of producing the characteristic 
signs of inflammation: vasodilatation, hyperemia, pain, edema, 
and cellular infiltration [9- 14] . For the demonstration of the 
activity of these metabolites the compounds are frequently 
injected into skin because this target tissue is accessible, re-
sponsive, and continuously observable. However, intradermal 
injection [15- 17] of AA and its metabolites bypasses the epi-
dermis which often is the first tissue affected by external insult. 
Accordingly we examined the effects of AA applied topically to 
mouse ears. 
The topical route, it was reasoned, would allow for continu-
ous, prolonged (at least several hours) delivery of AA to tissues 
(including epidermis [7]) which would transform it into appro-
priate inflammatory metabolites. 
We found, however, that topical application resulted in an 
abrupt, short-lived inflammatory response characterized by 
vasodilatation, tissue edema, protein leakage, and an inflam-
matory cell infiltrate. Although relatively high doses of AA are 
required to produce the full response, AA appears to be quite 
specific since even 8,11,14-eicosatrienoic acid, the PGE, pre-
cursor, produces no significant response alone or in combina-
tion with PGE" in contrast to the results reported by Kuehl et 
a! [18] . This short-lived response was not due to depletion of 
available, exogenous AA, since reapplication of AA at 6 or 24 h 
(Fig 3) produced no response with respect to edema or influx 
of inflammatory cells, although an increased erythema was 
observed. 
A remarkable feature of the AA-induced ear inflammation is 
t he rapid disappearance by 6 h of both PMNLs and monocytes, 
which histologic examination showed to be in the dermal inter-
stitium at 1 and 3 h. A radiolabeling method which does not 
discriminate between PMNLs and monocytes [3,5] provides 
confirmation of the histologic observations and clearly dist in-
guishes AA-induced inflammation from TPA-induced inflam-
mation in which a cellular infiltrate which persists for as long 
as 48 h. Further, the labeling studies confirmed the histologic 
observation [1] that cells which have emigrated from the vas-
culature do not appear to become activated and die in situ, but 
rather are capable of continued migration and rapid disappear-
ance from the extravascular compartment (Table 1). 
An additional major difference between AA- and TPA-in-
duced inflammations occurs with respect to the epidermis. TPA 
dramatically increases epidermal DNA synthesis and cell pro-
liferation, and produces a long-lasting hyperplasia presumably 
as a consequence of AA release and metabolism [1], while AA 
produces only a modest increase in epidermal DNA synthesis 
and mitotic counts at 24 h and at no time is hyperplasia 
observed. The modest effect observed is consistent with an 
indirect response to stretching of the epidermis produced by 
the edema [19]. Although AA and its metabolites are found at 
sites of chronic inflammation, our results show that AA alone 
produces only an acute response resulting in minimal cell and 
tissue damage. 
To assess the relative importance of the various AA metab-
olites, attempts were made to distinguish the relative roles of 
cyclooxygenase and lipoxygenase products using inhibitors of 
known specificity. The specificities were confirmed by us using 
an epidermal homogenate system [7] . Against the 4 mg dose of 
AA, naproxen, which is a quite specific inhibitor of cyclooxy-
genase, produced no significant inhibition, although it was 
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always observed t hat naproxen reduced the initial vasodilata-
t ion and erythema. In contrast, nordihydroguaiaretic acid and 
phenidone which inhibit lipoxygenase more than cyclooxygen-
ase consistently inhibited AA-induced edema without reducing 
vasodilatation. From these results it appeared that products of 
the cyclooxygenase pathway, particularly PGEz, contributed to 
increased blood flow t hrough a vasoc!ilatory action, but that 
products of the lipoxygenase pathway were necessary for vas-
cular leakage and edema consequent on cellular infiltrate [20) 
to occur. Supporting evidence for the major role of lipoxygenase 
products [21) is provided by the inhibitory effect of hydroqui-
none which in vitro inhibited epidermal lipoxygenase [7], but 
actually stimulated cyclooxygenase. Hydroquinone has fre-
quently been used as a cofactor to accelerate PG production by 
PG synthetase [22). Additionally, diphenyldisulfide, which is 
reported to be a specific inhibitor of lipoxygenase [8] was also 
found to be an effective inhibitor. 
The apparent lack of effect of cyclooxygenase inhibition was 
examined further by testing naproxen against lower doses of 
AA as shown in Fig 4. Against intermediate doses of AA (1.5 
and 2 mg), naproxen actually enhanced edema while reducing 
vasodilatation and erythema. This suggests that naproxen, 
which is a competitive cyclooxygenase inhibitor, produced at 
least partial blockade of t his pathway causing shunting of more 
AA into the lipoxygenase pathway. The inhibitory effect against 
t he 0.5 mg AA dose may be a resul t of more complete compet-
itive inhibition of cyclooxygenase or interference with penetra-
t ion. Since as li ttle as 0.04 mg AA produces marked vasodi la-
tation (a PGE2 effect) whereas a 10-fold greater dose is required 
to produce a half-maximal edema response (Fig 1B), it appears 
t hat small amounts of AA are preferentially metabolized by the 
cyclooxygenase pathway. Generation of chemoattractant lipox-
ygenase metaboli tes occurs only when the cyclooxygenase is 
overWhelmed by large amounts of AA, or subjected to inhibit ion 
with an agent such as naproxen. 
While PGs may act directly on receptors in cells of the 
vasculature to produce vasodilatation, the major role ascribed 
to lipoxygenase products is that of chemoattraction of inflam-
matory cells [21], and there is evidence indicating t hat with 
some mediators, inflammatory cells are required for the induc-
tion of vascular permeability [20) . Our results with topical 
application of AA showing the coincidence of int1ammatory cell 
infiltrate with the development of vascular leakage and tissue 
edema are consistent with this concept. In the mouse ear 
response to topical application of AA, it is clear that metabolism 
of AA via the lipoxygenase pathway is necessary for the pro-
duction of an edematous response. In t his respect, we have 
found the model satisfactory for the in vivo topical screening 
of putative lipoxygenase inhibitors. The investigation of effects 
of systemic administration of such inhibitors in this and other 
models of inflammation is ongoing and will be reported in due 
course. 
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